CERRT - Building the New York State RNA Workforce

RNA, long overlooked in the research world, is having its moment. The pandemic provided the rocket fuel, because mRNA vaccines essentially saved our way of life. Talk of RNA-based treatments and trials is suddenly commonplace.

It's all the talk in medicine. After decades at the forefront of RNA discovery, Rochester researchers are helping to write the next chapter

Host John Foxe, PhD sits down with Lynne Maquat, PhD to explore groundbreaking research in mRNA decay and other topics

Eric J. Wagner, PhD at the University of Rochester, was elected a fellow of the American Association for the Advancement of Science (AAAS)

Basic Research to Clinical Trials - Dr. Royzen's Work on Click Chemistry

The 2024 New York RNA Symposium was held October 14-15 in the Finger Lakes region

DM Mini Symposium With Focus on Newborn Screening

Mitchell O’Connell, PhD, an associate professor and member of the UofR's Center for RNA Biology and CERRT Advisory Board, has been appointed as Dean’s Associate Professor.

The New York State Center of Excellence in RNA Research and Therapeutics (CERRT) is excited to launch our new official website

Lynne E. Maquat, Ph.D., receives 2024 Dr. Paul Janssen Award for Biomedical Research for her fundamental discoveries about RNA decay

RNA-based technology facilitates effective use for difficult-to-treat, large-gene diseases

UAlbany Researcher and Spinoff Company Awarded NIH STTR Grants to Advance RNA Sequencing Technology

Lynne E. Maquat, PhD, receives the distinguished 2024 Albany Medical Center Prize in Medicine and Biomedical Research

New Center of Excellence in RNA Research and Therapeutics Celebrated on ‘World RNA Day’

Professor Andy Berglund Named Inaugural Keith Hynes Endowed Professor in STEM

The joint venture between the University of Rochester and University at Albany will drive economic development through research and training

Joint Venture Will Drive Economic Development Through Research, Partnerships with Industry

University of Rochester Medical Center Lueck Lab has identified the biological mechanism behind myotonic dystrophy type 1 (DM1)

Messenger RNA vaccines proved their worth in the COVID pandemic, and new software stands to make the technology even more powerful.